MARIA JOSEFA NATIVIDAD
GUERRA SEIJAS
Catedrática de universidad
![Foto de MARIA JOSEFA NATIVIDAD](/img/nophoto.png)
![Foto de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas](/img/noimage_org.png)
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (18)
2018
-
Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson’s Disease Models
Molecular Neurobiology, Vol. 55, Núm. 9, pp. 7297-7316
2017
-
Brain renin-angiotensin system and microglial polarization: Implications for aging and neurodegeneration
Frontiers in Aging Neuroscience, Vol. 9, Núm. MAY
-
Dopamine modulates astroglial and microglial activity via glial renin-angiotensin system in cultures
Brain, Behavior, and Immunity, Vol. 62, pp. 277-290
2016
-
Menopause and Parkinson's disease. Interaction between estrogens and brain renin-angiotensin system in dopaminergic degeneration
Frontiers in Neuroendocrinology, Vol. 43, pp. 44-59
2015
-
Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation
GLIA, Vol. 63, Núm. 3, pp. 466-482
-
Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinsons Disease
Neuroscientist, Vol. 21, Núm. 6, pp. 616-629
2014
-
Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with l-DOPA
Neuropharmacology, Vol. 76, Núm. PART A, pp. 156-168
-
Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death
Neuropharmacology, Vol. 85, pp. 1-8
2013
-
Brain angiotensin regulates iron homeostasis in dopaminergic neurons and microglial cells
Experimental Neurology, Vol. 250, pp. 384-396
2012
-
Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration
Neurobiology of Aging, Vol. 33, Núm. 1, pp. 204.e1-204.e11
-
Brain angiotensin and dopaminergic degeneration: Relevance to Parkinson’s disease
American Journal of Neurodegenerative Diseases, Vol. 1, Núm. 3, pp. 226-244
-
Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: Effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease
Journal of Neuroinflammation, Vol. 9
-
Involvement of microglial RhoA/Rho-Kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors
Neurobiology of Disease, Vol. 47, Núm. 2, pp. 268-279
-
Mitochondrial ATP-sensitive potassium channels enhance angiotensin-induced oxidative damage and dopaminergic neuron degeneration. Relevance for aging-associated susceptibility to Parkinson's disease
Age, Vol. 34, Núm. 4, pp. 863-880
2011
-
Aging, angiotensin system and dopaminergic degeneration in the substantia nigra
Aging and Disease, Vol. 2, Núm. 3, pp. 257-274
2010
-
Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: Implications for progression of Parkinson's disease
European Journal of Neuroscience, Vol. 32, Núm. 10, pp. 1695-1706
2009
-
Aging and sedentarism decrease vascularization and VEGF levels in the rat substantia nigra. Implications for Parkinson's disease
Journal of Cerebral Blood Flow and Metabolism, Vol. 29, Núm. 2, pp. 230-234
-
The mitochondrial ATP-sensitive potassium channel blocker 5-hydroxydecanoate inhibits toxicity of 6-hydroxydopamine on dopaminergic neurons
Neurotoxicity Research, Vol. 15, Núm. 1, pp. 82-95